{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:06:45Z","timestamp":1790017605063,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":986,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour, and Welfare of Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","journals.elsevierhealth.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ajpath.2016.12.016","type":"journal-article","created":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T23:45:18Z","timestamp":1486597518000},"page":"841-850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Blockade of p38 Mitogen-Activated Protein Kinase Inhibits Murine Sclerodermatous Chronic Graft-versus-Host Disease"],"prefix":"10.1016","volume":"187","author":[{"given":"Takashi","family":"Matsushita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutsumi","family":"Date","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyu","family":"Kano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kie","family":"Mizumaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momoko","family":"Tennichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadahiro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2016.12.016_bib1","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ajpath.2016.12.016_bib2","first-page":"325","article-title":"The role of TGF-beta signaling in the pathogenesis of fibrosis in scleroderma","volume":"50","author":"Ihn","year":"2002","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"Suppl 48","key":"10.1016\/j.ajpath.2016.12.016_bib3","first-page":"53","article-title":"Hypothesis for the pathogenesis of systemic sclerosis","volume":"24","author":"Furst","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ajpath.2016.12.016_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1573397052954109","article-title":"Characteristics of animal models for scleroderma","volume":"1","author":"Yamamoto","year":"2005","journal-title":"Curr Rheumatol Rev"},{"key":"10.1016\/j.ajpath.2016.12.016_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0008-8749(85)90086-3","article-title":"Chronic graft-versus-host disease as a model for scleroderma, II: mast cell depletion with deposition of immunoglobulins in the skin and fibrosis","volume":"94","author":"Claman","year":"1985","journal-title":"Cell Immunol"},{"key":"10.1016\/j.ajpath.2016.12.016_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1172\/JCI17601","article-title":"Memory CD4+ T cells do not induce graft-versus-host disease","volume":"112","author":"Anderson","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2016.12.016_bib7","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1182\/blood-2012-11-465658","article-title":"Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease","volume":"121","author":"Le Huu","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2016.12.016_bib8","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0092-8674(94)90277-1","article-title":"A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins","volume":"78","author":"Rouse","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2016.12.016_bib9","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0092-8674(94)90278-X","article-title":"Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27","volume":"78","author":"Freshney","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2016.12.016_bib10","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1126\/science.7914033","article-title":"A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells","volume":"265","author":"Han","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2016.12.016_bib11","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/372739a0","article-title":"A protein kinase involved in the regulation of inflammatory cytokine biosynthesis","volume":"372","author":"Lee","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2016.12.016_bib12","doi-asserted-by":"crossref","first-page":"e26999","DOI":"10.1371\/journal.pone.0026999","article-title":"Evolutionary history of the vertebrate mitogen activated protein kinases family","volume":"6","author":"Li","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2016.12.016_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0898-6568(99)00071-6","article-title":"The p38 signal transduction pathway: activation and function","volume":"12","author":"Ono","year":"2000","journal-title":"Cell Signal"},{"key":"10.1016\/j.ajpath.2016.12.016_bib14","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.1074\/jbc.270.13.7420","article-title":"Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine","volume":"270","author":"Raingeaud","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2016.12.016_bib15","doi-asserted-by":"crossref","first-page":"10531","DOI":"10.1073\/pnas.92.23.10531","article-title":"Mxi2, a mitogen-activated protein kinase that recognizes and phosphorylates Max protein","volume":"92","author":"Zervos","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2016.12.016_bib16","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/art.24485","article-title":"Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies","volume":"60","author":"Damjanov","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2016.12.016_bib17","first-page":"1020","article-title":"Drug evaluation: VX-702, a MAP kinase inhibitor for rheumatoid arthritis and acute coronary syndrome","volume":"7","author":"Ding","year":"2006","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.ajpath.2016.12.016_bib18","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3899\/jrheum.100602","article-title":"A 24-week, randomized, double-blind, placebo-controlled, parallel group study of the efficacy of oral SCIO-469, a p38 mitogen-activated protein kinase inhibitor, in patients with active rheumatoid arthritis","volume":"38","author":"Genovese","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ajpath.2016.12.016_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/art.24266","article-title":"Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis","volume":"60","author":"Cohen","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2016.12.016_bib20","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1523-1747.2002.01719.x","article-title":"Role of p38 MAPK in transforming growth factor beta stimulation of collagen production by scleroderma and healthy dermal fibroblasts","volume":"118","author":"Sato","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2016.12.016_bib21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.0022-202X.2005.23766.x","article-title":"Increased phosphorylation and activation of mitogen-activated protein kinase p38 in scleroderma fibroblasts","volume":"125","author":"Ihn","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2016.12.016_bib22","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1038\/jid.2012.226","article-title":"IL-6 blockade attenuates the development of murine sclerodermatous chronic graft-versus-host disease","volume":"132","author":"Le Huu","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2016.12.016_bib23","doi-asserted-by":"crossref","first-page":"698","DOI":"10.4049\/jimmunol.179.1.698","article-title":"Intercellular adhesion molecule-1 deficiency attenuates the development of skin fibrosis in tight-skin mice","volume":"179","author":"Matsushita","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2016.12.016_bib24","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.4049\/jimmunol.168.6.3088","article-title":"Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation","volume":"168","author":"Zhang","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2016.12.016_bib25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10067-010-1610-4","article-title":"Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis","volume":"30","author":"Hasegawa","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ajpath.2016.12.016_bib26","first-page":"275","article-title":"Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis","volume":"33","author":"Matsushita","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ajpath.2016.12.016_bib27","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.0022-202X.2005.23767.x","article-title":"Abnormal natural killer cell function in systemic sclerosis: altered cytokine production and defective killing activity","volume":"125","author":"Horikawa","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2016.12.016_bib28","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/320584a0","article-title":"Cachectin and tumour necrosis factor as two sides of the same biological coin","volume":"320","author":"Beutler","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2016.12.016_bib29","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0022-202X(89)90185-1","article-title":"Differential regulation of collagen, glycosaminoglycan, fibronectin, and collagenase activity production in cultured human adult dermal fibroblasts by interleukin 1-alpha and beta and tumor necrosis factor-alpha and beta","volume":"92","author":"Duncan","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2016.12.016_bib30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1006\/cimm.1999.1537","article-title":"A role for T helper 2 cells in mediating skin fibrosis in tight-skin mice","volume":"196","author":"Ong","year":"1999","journal-title":"Cell Immunol"},{"key":"10.1016\/j.ajpath.2016.12.016_bib31","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1038\/sj.jid.5700919","article-title":"BAFF antagonist attenuates the development of skin fibrosis in tight-skin mice","volume":"127","author":"Matsushita","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2016.12.016_bib32","first-page":"755","article-title":"Hypothesis: pathogenesis of systemic sclerosis","volume":"30","author":"Takehara","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ajpath.2016.12.016_bib33","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ajpath.2016.12.016_bib34","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/gt.2011.159","article-title":"Effect of topical interferon-gamma gene therapy using gemini nanoparticles on pathophysiological markers of cutaneous scleroderma in Tsk\/+ mice","volume":"19","author":"Badea","year":"2012","journal-title":"Gene Ther"},{"key":"10.1016\/j.ajpath.2016.12.016_bib35","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s004030000136","article-title":"Effect of interferon-gamma on experimental scleroderma induced by bleomycin","volume":"292","author":"Yamamoto","year":"2000","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.ajpath.2016.12.016_bib36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/1529-0131(199904)42:4<609::AID-ANR3>3.0.CO;2-I","article-title":"Signal transduction and transcription factors in rheumatic disease","volume":"42","author":"Firestein","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2016.12.016_bib37","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1074\/jbc.274.1.158","article-title":"UV irradiation activates JNK and increases alphaI(I) collagen gene expression in rat hepatic stellate cells","volume":"274","author":"Chen","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2016.12.016_bib38","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1046\/j.1523-1755.1999.00733.x","article-title":"TGF-beta1 activates MAP kinase in human mesangial cells: a possible role in collagen expression","volume":"56","author":"Hayashida","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajpath.2016.12.016_bib39","doi-asserted-by":"crossref","first-page":"34634","DOI":"10.1074\/jbc.C000175200","article-title":"Activation of extracellular signal-regulated kinase 1\/2 inhibits type I collagen expression by human skin fibroblasts","volume":"275","author":"Reunanen","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2016.12.016_bib40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0092-8674(00)00116-1","article-title":"Signal transduction by the JNK group of MAP kinases","volume":"103","author":"Davis","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2016.12.016_bib41","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1172\/JCI9362","article-title":"c-Jun-dependent inhibition of cutaneous procollagen transcription following ultraviolet irradiation is reversed by all-trans retinoic acid","volume":"106","author":"Fisher","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2016.12.016_bib42","doi-asserted-by":"crossref","first-page":"L103","DOI":"10.1152\/ajplung.00187.2001","article-title":"A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis","volume":"283","author":"Matsuoka","year":"2002","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.ajpath.2016.12.016_bib43","doi-asserted-by":"crossref","first-page":"L895","DOI":"10.1152\/ajplung.2000.279.5.L895","article-title":"SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung","volume":"279","author":"Underwood","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.ajpath.2016.12.016_bib44","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1093\/ndt\/gfn309","article-title":"Delayed inhibition of p38 mitogen-activated protein kinase ameliorates renal fibrosis in obstructive nephropathy","volume":"23","author":"Nishida","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ajpath.2016.12.016_bib45","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/01.ASN.0000109669.23650.56","article-title":"The role of p38 alpha mitogen-activated protein kinase activation in renal fibrosis","volume":"15","author":"Stambe","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ajpath.2016.12.016_bib46","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.jse.2016.01.035","article-title":"Inhibition of p38 mitogen-activated protein kinase signaling reduces fibrosis and lipid accumulation after rotator cuff repair","volume":"25","author":"Wilde","year":"2016","journal-title":"J Shoulder Elbow Surg"},{"key":"10.1016\/j.ajpath.2016.12.016_bib47","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nbt0411-301","article-title":"p38 Kinase inhibitor approved for idiopathic pulmonary fibrosis","volume":"29","author":"Moran","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ajpath.2016.12.016_bib48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/JAA.S4199","article-title":"Selective p38alpha mitogen-activated protein kinase inhibitor attenuates lung inflammation and fibrosis in IL-13 transgenic mouse model of asthma","volume":"1","author":"Ma","year":"2008","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.ajpath.2016.12.016_bib49","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/gut.50.4.507","article-title":"Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitis","volume":"50","author":"ten Hove","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2016.12.016_bib50","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.3748\/wjg.14.5851","article-title":"FR167653, a p38 mitogen-activated protein kinase inhibitor, aggravates experimental colitis in mice","volume":"14","author":"Nishimura","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ajpath.2016.12.016_bib51","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1096\/fj.04-1642fje","article-title":"Inhibition of p38 MAP kinase- and RICK\/NF-kappa B-signaling suppresses inflammatory bowel disease","volume":"18","author":"Hollenbach","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2016.12.016_bib52","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/j.1460-2075.1996.tb00542.x","article-title":"The p38\/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor","volume":"15","author":"Beyaert","year":"1996","journal-title":"EMBO J"},{"key":"10.1016\/j.ajpath.2016.12.016_bib53","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/rheumatology\/kem297","article-title":"MAPKs and their relevance to arthritis and inflammation","volume":"47","author":"Thalhamer","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.ajpath.2016.12.016_bib54","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K","article-title":"Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis","volume":"43","author":"Schett","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2016.12.016_bib55","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1002\/art.11227","article-title":"Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653","volume":"48","author":"Nishikawa","year":"2003","journal-title":"Arthritis Rheum"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944017300664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944017300664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T07:15:47Z","timestamp":1576221347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944017300664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0002944017300664"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2016.12.016","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blockade of p38 Mitogen-Activated Protein Kinase Inhibits Murine Sclerodermatous Chronic Graft-versus-Host Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2016.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}